ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM) (1999)
Cruz, J. W. M. C.; Hohman, T.; Fortes, Zuleica Bruno
Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, J. W. M. C. e HOHMAN, T. e FORTES, Zuleica Bruno. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 1999
APA
Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Cruz JWMC, Hohman T, Fortes ZB. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Vancouver
Cruz JWMC, Hohman T, Fortes ZB. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Trabalho de evento-resumo periodico
Non-steroidal antinflammatory drug and calcium channel blocker: influence on leukocyte-endothelium interaction in rats (1999)
Martinez, L. L.; Oliveira, M. A.; Fortes, Zuleica Bruno
Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARTINEZ, L. L. e OLIVEIRA, M. A. e FORTES, Zuleica Bruno. Non-steroidal antinflammatory drug and calcium channel blocker: influence on leukocyte-endothelium interaction in rats. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 1999
APA
Martinez, L. L., Oliveira, M. A., & Fortes, Z. B. (1999). Non-steroidal antinflammatory drug and calcium channel blocker: influence on leukocyte-endothelium interaction in rats. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Martinez LL, Oliveira MA, Fortes ZB. Non-steroidal antinflammatory drug and calcium channel blocker: influence on leukocyte-endothelium interaction in rats. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Vancouver
Martinez LL, Oliveira MA, Fortes ZB. Non-steroidal antinflammatory drug and calcium channel blocker: influence on leukocyte-endothelium interaction in rats. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Trabalho de evento-resumo periodico
Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications (1999)
Cruz, J. W. M. C.; Hohman, T.; Fortes, Zuleica Bruno
Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CRUZ, J. W. M. C. e HOHMAN, T. e FORTES, Zuleica Bruno. Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 1999
APA
Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Vancouver
Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Trabalho de evento-resumo periodico
Vitamin C treatment and defective endothelial-leukocyte interaction in diabetes mellitus (1999)
Zanardo, R. C. O.; Oliveira, M. A.; Fortes, Zuleica Bruno
Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANARDO, R. C. O. e OLIVEIRA, M. A. e FORTES, Zuleica Bruno. Vitamin C treatment and defective endothelial-leukocyte interaction in diabetes mellitus. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 1999
APA
Zanardo, R. C. O., Oliveira, M. A., & Fortes, Z. B. (1999). Vitamin C treatment and defective endothelial-leukocyte interaction in diabetes mellitus. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Zanardo RCO, Oliveira MA, Fortes ZB. Vitamin C treatment and defective endothelial-leukocyte interaction in diabetes mellitus. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Vancouver
Zanardo RCO, Oliveira MA, Fortes ZB. Vitamin C treatment and defective endothelial-leukocyte interaction in diabetes mellitus. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Trabalho de evento-resumo periodico
Downregulation of ICAM-1 (CD54) by plasma in diabetes mellitus (1999)
Anjos-Valotta, E. A.; Oliveira, M. A.; Britto, Luiz Roberto Giorgetti de ; Fortes, Zuleica Bruno; Sannomiya, Paulina
Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANJOS-VALOTTA, E. A. et al. Downregulation of ICAM-1 (CD54) by plasma in diabetes mellitus. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 1999
APA
Anjos-Valotta, E. A., Oliveira, M. A., Britto, L. R. G. de, Fortes, Z. B., & Sannomiya, P. (1999). Downregulation of ICAM-1 (CD54) by plasma in diabetes mellitus. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Anjos-Valotta EA, Oliveira MA, Britto LRG de, Fortes ZB, Sannomiya P. Downregulation of ICAM-1 (CD54) by plasma in diabetes mellitus. Mediators of Inflammation. 1999 ; 8( 1): S92.[citado 2024 maio 25 ]
Vancouver
Anjos-Valotta EA, Oliveira MA, Britto LRG de, Fortes ZB, Sannomiya P. Downregulation of ICAM-1 (CD54) by plasma in diabetes mellitus. Mediators of Inflammation. 1999 ; 8( 1): S92.[citado 2024 maio 25 ]
Trabalho de evento-resumo periodico
Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation (1999)
Akamine, Eliana Hiromi ; Cruz, J. W. M. C.; Hohman, T.; Fortes, Zuleica Bruno
Source: Mediators of Inflammation. Conference titles: World Congress on Inflamation. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AKAMINE, Eliana Hiromi et al. Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 25 maio 2024. , 1999
APA
Akamine, E. H., Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
NLM
Akamine EH, Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]
Vancouver
Akamine EH, Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. 1999 ; 8( 1):[citado 2024 maio 25 ]

USP Schools

ReP

Filtros

Authors